Sutro Biopharma (STRO) Times Interest Earned (2017 - 2022)

Sutro Biopharma has disclosed Times Interest Earned across 6 years of filings, most recently posting -$7.61 for Q3 2022.

• Times Interest Earned for Q3 2022 came in at -$7.61, up 82.01% year-over-year; the trailing twelve-month figure through Jun 2023 was -$56.98 (down 19.22% YoY), and the FY2021 annual result was -$31.41, down 80.2% from the prior year.
• Times Interest Earned came in at -$7.61 for Q3 2022 at Sutro Biopharma, up from -$32.62 in the prior quarter.
• In the past five years, Times Interest Earned ranged from a high of $23.84 in Q2 2018 to a low of -$59.56 in Q1 2022.
• The 5-year median for Times Interest Earned is -$12.3 (2019), against an average of -$17.14.
• Across the five-year window, Times Interest Earned surged 161.0% in 2020 and plunged 822.81% in 2021, its largest moves.
• Sutro Biopharma's Times Interest Earned stood at $5.05 in 2018, then plunged by 458.55% to -$18.09 in 2019, then jumped by 161.0% to $11.04 in 2020, then tumbled by 618.72% to -$57.25 in 2021, then surged by 86.71% to -$7.61 in 2022.
• The last three Times Interest Earned figures came in at -$7.61 (Q3 2022), -$32.62 (Q2 2022), and -$59.56 (Q1 2022), per Business Quant data.